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Introduction: New fungal species are increasingly reported in immunocompromised
patients. Saprochaete clavata (S. clavata), an ascomycetous fungus formerly
called Geotrichum clavatum, is intrinsically resistant to echinocandins and is
often misidentified.
Objective: We describe a cluster of seven S. clavata infections in hospitalized
hematology patients who developed this rare fungemia within a span of 11 months.
Three of the seven patients died. Identification of the isolates was determined only with
the Saramis database of VitekMS system and sequencing of the internal transcribed
spacer (ITS) region. Clonal relatedness of the isolates was determined by matrix-assisted
laser desorption ionization–time of flight mass spectrometry (MALDI-TOF) analysis;
clonal correlation between the strains was investigated by means of phylogenetic
analysis, based on single-nucleotide variants (SNPs). Clinical presentation, 1–3 β-D-
glucan (BG) and galactomannan (GM) antigen results and analysis of possible sources of
contamination are also described with a prospective case–control study of the outbreak.
Results: MALDI-TOF MS-Vitek (bioMerieux, Marcy l’Etoile, France) failed to identify the
six isolates, while SARAMIS (bioMerieux, Marcy l’Etoile, France) identified the isolates
as S. clavata. Initially, Vitek 2 identified the strains as Geotrichum capitatum in two
of the seven cases. Molecular identification gave 99% homology with S. clavata. BG
was positive in three out of six patients (range 159 to >523 pg/ml), GM results
were always negative. All the isolates were resistant to echinocandins (anidulafungin,
micafungin, and caspofungin) and Fluconazole, but susceptible to Flucytosine and
Voriconazole. One isolate showed acquired resistance to Flucytosine and Amphotericin
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B during treatment. Both the correlation-based dendrograms obtained by MALDI-TOF
MS (Bruker Daltonics) and MS-Vitek not only clustered six of the seven bloodstream
infection (BSI) isolates in the same group, but also showed their strong relatedness.
Phylogenetic analysis using SNPrelate showed that the seven samples recorded during
the investigation period clustered together. We observed a split between one case and
the remainder with a node supported by a z-score of 2.3 (p-value = 0.021) and 16
mutations unique to each branch.
Conclusion: The use of proteomics for identification and evaluation of strain clonality in
outbreaks of rare pathogens is a promising alternative to laborious and time-consuming
molecular methods, even if molecular whole-genome sequencing (WGS) typing will still
remain the reference method for rare emergent pathogens.
Keywords: Saprochaete, MALDI-TOF, yeast sepsi, outbreak, whole-genome sequencing
INTRODUCTION
Invasive fungal infections (IFIs) represent a public health burden
worldwide, especially in immunocompromised patients, and
their incidence has risen over the last decades due to the increased
use of immunosuppressive and cytotoxic therapies, improved
diagnostic techniques, greater awareness, and clinical suspicion.
They are still a major cause of morbidity and mortality in
patients with hematology malignancies (Girmenia et al., 2005;
Miceli et al., 2011; Garcia-Ruiz et al., 2013; Picard et al., 2014;
Stanzani et al., 2019). Candida and Aspergillus spp. play a
major role. However, as a result of new prevention strategies,
changes in host features and treatment protocols, new species are
increasingly reported as agents of blood stream infections (BSIs)
or disseminated fungi such as Trichosporon and Geotrichum
(Girmenia et al., 2005; Miceli et al., 2011; Litvintseva et al., 2014;
Picard et al., 2014). Particularly, Geotrichum, an arthroconidial
yeast-like filamentous fungus whose nomenclature has recently
been modified, demands special attention owing to recent
outbreaks in hematology patients. Because our knowledge of
these new species is poor, although improving, it is still difficult
to distinguish between one fungus and another. For example,
Magnusiomyces clavatus, formerly known as Saprochaete clavata
or Geotrichum clavatum, is phylogenetically and phenotypically
closely related to Magnusiomyces capitatus, formerly called
Geotrichum capitatum. Both species are often misidentified and
have been implicated in sporadic cases and outbreaks of fungemia
mostly, but not only, in Mediterranean countries (Garcia-Ruiz
et al., 2013; Desnos-Ollivier et al., 2014; Del Principe et al.,
2016). Because of this microbiological flaw, and their intrinsic
resistance to echinocandins and fluconazole, these infections
restrict therapeutic options and are associated with high mortality
rates. Here we present a prospective case–control study about an
outbreak of S. clavata BSIs in adult and pediatric hematology
patients of the Azienda Ospedaliera Universitaria Integrata di
Verona, Italy, which occurred between September 2016 and July
2017. In order to provide clues about the isolates’ relatedness,
typing by matrix-assisted laser desorption ionization–time of
flight mass spectrometry (MALDI-TOF) analysis was performed.
Finally, clonal correlation between the strains was investigated
by means of phylogenetic analysis based on single-nucleotide
variants (SNPs). Clinical presentation, 1–3 β-D-glucan (BG), and
galactomannan (GM) antigen results and analysis of possible
sources of contamination are also described.
MATERIALS AND METHODS
Epidemiology Study
In order to limit the spread and to look for a common
source of the infection, the hospital infection control and
epidemiology teams, by agreement with the Medical Direction,
organized a case–control study. From September 2016 to July
2017 a matched density-based sampling case–control study was
undertaken, in order to investigate risk factors for Saprochaete
fungemia in hematology patients hospitalized in the Azienda
Ospedaliera Universitaria Integrata di Verona, Italy. Included
cases were patients whose blood cultures proved positive for
Saprochaete and who were hospitalized in the hematology,
bone marrow transplant, and pediatric onco-hematology wards.
Controls were patients hospitalized within 2 months prior to
the isolation of Saprochaete from blood cultures of each case
and with a minimum of 10 days’ hospitalization in the same
wards. Each case was matched with five controls, based on
hospital ward, during clinical presentation of fungal sepsis.
Information about comorbidities, chemotherapy, antimicrobial
therapy, presence of indwelling catheters, transfusions, and
nutrition were collected by examining patient medical files, food
database from the organization which provided patient meals,
Hematology database, and the Hospital Pharmacy. Given this
rare infection, it has not been possible to precisely estimate the
sample size and the statistical power. Owing to scant literature on
this topic, almost always limited to small cluster epidemics and
case series, we chose to perform a conditioned regression logistic
analysis, considering a p-value < 0.05 as statistically significant.
This retrospective observational study was based on
anonymized patient data, and was carried out in accordance with
the Declaration of Helsinki, under the terms of relevant local
legislation, and was cleared by the Institutional Review Board.
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The requirement for informed consent was waived due to the
observational and retrospective nature of this study.
Microbiological Study
The Bact/Alert3D (bioMerieux, Marcy l’Etoile, France) system
was used for blood cultures. A minimum of two culture vials
per patient in 24 h, one fastidious antibiotic neutralization (FAN)
aerobic bottle and one FAN anaerobic bottle (bioMerieux, Marcy
l’Etoile, France), were filled directly with blood according to
the manufacturer’s instructions. Cultures were incubated for a
maximum of 5 days. On positive bottles gram staining was
performed to allow direct microscopy, cultures were inoculated
and incubated on Blood agar, Chocolate agar, Columbia agar
(supplemented with 5% sheep blood), Sabouraud dextrose agar,
and Schaedler agar under aerobic, micro-aerobic, and anaerobic
conditions, respectively.
Identification of the blood isolates was undertaken using
various methods, namely MS Vitek MALDI-TOF, SARAMIS,
and VITEK 2(System (bioMerieux, Marcy l’Etoile, France).
Primers ITS1 and ITS4 were used to amplify rDNA ITS
region (White et al., 1990), while primers NL1 and NL4 were
used to amplify rDNA D1–D2 region (Kurtzman and Robnett,
1997). Amplified sequences were compared with the GenBank
Nucleotide Database1 using the algorithm Blast N (Altschul
et al., 1997; de Hoog and Smith, 2004; Nilsson et al., 2006;
Bader et al., 2011).
Serum BG levels were determined by the Food and
Drug Administration-approved Fungitell Assay (Associates
of Cape Cod, Falmouth, MA, United States) according
to the manufacturer’s instructions (Budhavari, 2009). BG
values < 60 pg/mL were interpreted as being negative,
>80 pg/mL as being positive, and 60–79 pg/mL as indeterminate.
Serum GM levels were determined by Platelia Aspergillus
(Bio-Rad, Marnes-la-Coquette, France) according to the
manufacturer’s recommendations. As cleared by the US FDA the
results were analyzed using an optical density (OD) index cut-off
value of 0.5 on serum. The test was considered positive with an
OD index value of ≥0.8 or more rather than with an OD index of
0.5 in two consecutive samples (Favre et al., 2016).
In vitro susceptibilities to amphotericin B, fluconazole,
itraconazole, voriconazole, posaconazole, anidulafungin,
caspofungin, micafungin, and flucytosine were determined by
Sensititre YeastOne Y10 panel (Thermo Fisher Inc.). Readings
were taken at 24 and 48 h of incubation.
In order to provide clues about the isolates’ relatedness,
MALDI-TOF analysis was performed after the acquisition of the
mass spectrum profiles in positive linear mode by a Microflex LT
mass spectrometer (MSP, Bruker Daltonics) in accordance with
the manufacturers’ recommendations. Strains of M. capitatus
and S. clavata belonging to collected strain of UCSC-Rome were
evaluated to show any correlation. Following MSP creation from
the seven isolates, a score-oriented dendrogram was generated
from hierarchical cluster analysis using the integrated statistical
tool of the BioTyper 3.1 software. Hence, the same analysis
was done with SARAMIS software connected to MS-Vitek in
1http://www.ncbi.nlm.nih.gov
accordance with the manufacturers’ instructions. To evaluate
any aspecific correlation, strains of S. clavata and Geotrichum
candidum were submitted for the same analysis.
An environmental study was conducted to investigate
possible sources of infection. Medical devices, drugs, blood-
derived products and foods, in particular dairy products,
were cultured for enrichment in Brain hearth infusion
(BHI) broth and subculture in Blood agar, Chocolate agar,
Columbia agar (supplemented with 5% sheep blood), and
Sabouraud dextrose agar.
Genotyping Methods
All the strains of S. clavata occurring in the Verona outbreak
and three strains of Saprochaete capitata, which had been
isolated in another Italian hospital (Milan), were used to
compare clonal correlation. All yeasts were sequenced. PCR-
free DNAseq libraries were generated with the KAPA Hyper
prep. Library kit. The sequencing process was based on an
Illumina NextSeq500 using 2 × 150 bp-reads, analyzing 19.3
million fragments per sample on average. Figure 1 shows the
workflow used in this study, which involved a number of steps
from raw fastq files to the production of a phylogenetic tree.
In the first step, adapters removal and quality trimming were
performed using shyte v.0.991 and sickle v.1.33 software to obtain
high quality reads. Then, reads were aligned to the S. clavata
reference assembly produced by Vaux et al. (2014) (17.5 Mb,
339 scaffolds), using mem algorithm of burrows wheeler aligner
v.0.7.17 with default options except when a threads argument
was available. The BAM files obtained from reads alignment
were used to call variants. This step in the pipeline was done
using mpileup command from samtools v.1.4. The genotyping
was performed using call command from bcftools v.1.4. All the
variant calls were filtered following criteria set in Vaux et al.
(2014): (i) all the variants were supported at least with four
reads for each orientation; (ii) all the reads with a mapping
quality above 30 were considered; (iii) variants at <100 bp from
the margins of a scaffold were excluded; and (iv) the variable
characters were parsimony informative (containing more than
one type of nucleotide, occurring at least in two isolates) to
support phylogenetic clustering. Phylogenetic correlation was
inferred from high quality SNPs. R packages SNPrelate v.3.7
and Ape/Phangorn v.2.4.0 were used to compute a nucleotide
distance matrix and then to perform the clustering step using a
neighbor joining algorithm. To support the phylogenetic analysis
with a different clustering technique, the principal component
analysis was applied. Normalization of SNPs number per scaffold
length was performed to check for hypervariable regions possibly
connected to Fungi adaptations. The hypervariable scaffold
sequences were aligned with “Basic Local Alignment Search Tool”
to search for similarities with NCBI database.
RESULTS
During the study period, a total of seven cases of S. clavata BSIs
occurred in different hematology wards of our hospital
(Figure 2). Thirty-five controls were enrolled. Table 1
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FIGURE 1 | Workflow used to produce the phylogenetic tree of isolated Saprochaete.
FIGURE 2 | Epidemiological curve of Saprochaete clavata infections. The cases are designated with letters which identify the isolate, with boxes corresponding to
the date of the first positive blood culture.
summarizes the main characteristics of cases and controls.
All but one of the patients were Italians. The mean ages of
cases and controls were 41.1 and 51 years, respectively. Six
(85.7%) cases and 18 (51.4%) controls were male. Underlying
disease was acute myeloid leukemia (AML) in two of the seven
cases, non-Hodgkin lymphoma in two, acute T-lymphoblastic
leukemia in one, and other unspecified hematology diseases in
the remaining two. It is noteworthy that all of the cases had a
Frontiers in Microbiology | www.frontiersin.org 4 January 2020 | Volume 11 | Article 84
fmicb-11-00084 January 29, 2020 Time: 17:23 # 5
Lo Cascio et al. Saprochaete clavata Outbreak Investigation Strategy
TABLE 1 | Characteristics of the Saprochaete cases.
Characteristics Cases N (%) Controls N (%)
Sex female add a line with number of
male patients and controls?
1 (14.3) 17 (48.6)
Mean age (SD) 41.1 (26.1) 51.0 (22.0)
Age in range
0–40 3 (42.7) 8 (22.3)
41–50 1 (14.3) 4 (11.4)
51–60 1 (14.3) 9 (25.7)
61–70 2 (28.6) 10 (28.6)
>70 – 4 (11.4)
Transfer to other UO what is UO? 2 (28.6) 10 (28.6)
Underlying diseases or conditions
Acute myeloid leukemia 2 (28.6) 10 (28.6)
Chronic myeloid leukemia – 2 (5.7)
Lymphoma 2 (28.6) 14 (40.0)
Multiple myeloma – 3 (8.6)
Other 3 (42.9) 6 (17.1)
Charlson co-morbidity score,
media (DS)
3 (1.8) 4.3 (2.0)
Charlson score in range
0–3 4 (57.1) 11 (31.4)
4–7 3 (42.9) 21 (60.0)
8–11 – 3 (8.6)
Barthel scale, mean (SD) 86.7 (21.8) 88.2 (19.6)
Dead, N(%) 3 (42.9) 2 (5.7)
Presence of CVC during recovery 7 (100) 32 (31.4)
Days with CVC
0–20 2 (28.6) 18 (51.4)
21–40 – 10 (28.6)
>40 5 (71.4) 7 (20.0)
Days of CVC, mean (IQR) 64 (18–78) 20 (15–30)
Mechanical ventilation 1 (14.3) 2 (5.7)
Bladder catheter 3 (42.9) 9 (25.7)
Chemotherapy 7 (100) 29 (82.9)
Immunosuppression 7 (100) 24 (68.6)
Antibiotics 7 (100) 33 (94.3)
Aminoglycosides 6 (85.7) 11 (31.4)
Days with aminoglycosides, mean (SD) 11.4 (11.6) 0 (0.7)
Penicillin with beta-lactamases inhibitor 5 (71.4) 17 (48.6)
Days with penicillin with BL inhibitor,
mean (SD)
5.5 (5.1) 4.0 (5.9)
Cephalosporins 3–4◦ gen. 3 (42.9) 13 (37.1)
Days with cephalosporins 3–4◦ gen.,
mean (SD)
7.1 (11.7) 3.9 (7.1)
Fluorochinolons 2 (28.2) 13 (37.1)
Days with fluorochinolons, mean (SD) 3.8 (9.4) 7.0 (11.1)
Glycopeptides, N(%) 4 (57.1) 9 (25.7)
Days with glycopeptides, mean(SD) 8.4 (12.0) 2.7(85.2)
Meropenem 5 (71.4) 5 (14.3)
Days with meropenem, mean (SD) 7.3 (10.0) 2.1 (8.6)
Co-trimoxazole 1 (14.3) 5 (14.3)
Days with co-trimoxazole, mean (SD) 0.3 (0.8) 0.6 (1.7)
Antifungals 4 (57.1) 26 (74.3)
Amphotericin 3 4
Days with amphotericin B, mean (SD) 2.9 (4.3) 2.6 (9.9)
(Continued)
TABLE 1 | Continued
Characteristics Cases N (%) Controls N (%)
Azols 2 25
Days with azols, mean (SD) 9.4 (19.5) 13.6 (11.5)
Echinocandins 2 2
Days with echinocandins, mean (SD) 3 (5.5) 0.4 (1.8)
HSCT 2 (28.6) 8 (22.9)
Days from the HSCT, mean (SD) 33 (22.6) 20.1 (9.0)
Proton pump inhibitors (PPI) 4 (57.1) 24 (68.6)
Neutropenia 7 (100) 30 (85.7)
Nadir of neutrophils, mean (DS) 11.4 (3.89) 121 (262.5)
Days with neutropenia, mean (DS) 23 (15.1) 9.9 (6.8)
Days with neutropenia in range
0–10 3 (42.3) 18 (60.0)
11–20 – 10 (33.3)
>20 4 (57.1) 2 (6.7)
Growth factors 5 (71.4) 21 (60.0)
Mucositis 3 (42.9) 7 (20.0)
Diarrhea 6 (85.7) 17 (48.6)
Transfusion with RC 7 (100) 30 (85.7)
Number of red cell transfusion,
mean (SD)
12.4 (9.7) 4.1 (3.3)
Plasma transfusion 4 (57.1) 4 (11.4)
Number of plasma transfusion,
mean (SD)
3.1 (3.5) 0.3(1.0)
Platelet transfusion 7 (100) 26 (74.3)
Number of platelet transfusion,
mean (SD)
14.4(11.7) 2.8(3.6)
central venous catheter (CVC) inserted at clinical presentation
of sepsis, with a mean duration of 64 days, and positive blood
cultures. All of them had undergone a course of chemotherapy
before the infection occurred (three out of seven with cytarabine),
they were neutropenic at the time of fungemia and were also
given broad-spectrum antibiotics. On univariate analysis, risk
factors strongly correlated to development of fungemia were
the duration of neutropenia (p = 0.011; OR = 1.1; 95% CI, 1.0–
1.18), the receipt of plasma transfusions (p = 0.022; OR = 13.7;
95% CI, 1.4–128.7), the number of transfusions of blood and
platelets (p = 0.029; OR = 1.4; 95% CI, 1.0–1.8), the use of
aminoglycosides (p = 0.025; OR = 12.5; 95% CI, 1.4–113.2) and
meropenem (p = 0.011; OR = 8.8; 95% CI, 1.7–47.0) (Table 2).
Microscopy of positive blood cultures showed yeast-like cells
(Figure 3), while cultures on Sabouraud agar showed farinose and
TABLE 2 | Conditioned univariate logistic regression analysis for
Saprochaete-positive blood cultures risk factors.
Variable OR (95% CI) P-value
Aminoglycosides use 12.5 (1.4–113.2) 0.025
Meropenem use 8.8 (1.7–47.0) 0.011
Duration of neutropenia in days 1.1 (1.0–1.18) 0.011
Plasma transfusion 13.7 (1.4–128.7) 0.022
Number of transfused platelet unity 1.4 (1.0–1.8) 0.029
Duration of aminoglycosides therapy (days) 1.2 (1.0–1.4) 0.040
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FIGURE 3 | Microscopic morphology of Saprochaete clavata in positive blood
cultures showing yeast-like cells.
FIGURE 4 | Culture of Saprochaete clavata on Sabouraud dextrose agar.
dry yeast colonies (Figure 4). All the isolates were from blood and
one patient also had an isolate from stool. Two of the seven BSI
strains were identified as G. capitatum by Vitek-2, while MALDI-
TOF MS-Vitek (bioMerieux, Marcy l’Etoile, France) did not
give any precise identification. Use of RUO SARAMIS MALDI-
TOF database (bioMerieux, Marcy l’Etoile, France) and gene
sequencing of the D1D2 and ITS1-5.8S-ITS2 regions identified all
the isolates as S. clavata subspecies clavata with 99% homology.
β-D-glucan test was positive in three out of seven cases (range
159 to >523 pg/mL), while serum GM antigen results (Platelia
Aspergillus – Bio-Rad, France) were all negative.
All the seven isolates were resistant to echinocandins and
fluconazole (MIC for anidulafungin, micafungin, caspofungin 2,
8, and 8 mg/L, respectively; MIC for fluconazole 16 mg/L).
The strains were susceptible to flucytosine (MIC range
0.12–0.25 mg/L), voriconazole (MIC range 0.25–0.5 mg/L),
and amphotericin B (MIC range 0.5–1 mg/L). One isolate
showed acquired resistance to flucytosine and amphotericin B
during treatment.
In the genotyping analysis, both the correlation-based
dendrograms obtained by MALDI-TOF MS (Bruker Daltonics)
and MS-Vitek not only clustered six of the seven BSI isolates
in the same group, but also showed their strong relatedness
(Figure 5). Bruker software correctly distinguished M. capitatus
from S. clavata, and clustered the first six strains of our outbreak
together. The second analysis with SARAMIS-MS Vitek software
was carried out after the seventh case occurred. In the last patient
(ZY075) S. clavata was isolated from blood and from stool and
both isolates were analyzed. The SARAMIS analysis clustered
these S. clavata strains together, except for the TN293 strain
which appeared moderately far away from the others, and closest
to the VR00018 strain, not involved in the outbreak. SARAMIS
analysis well differentiated S. clavata from G. candidum.
The genotyping analysis was performed on S. clavata strains
belonging to the Verona outbreak and from another hospital in
Milan, during the same year.
After comparing our isolates with those from Milan, the
mapping procedure gave 17.5 million mapped fragments on
average, with a median coverage of 262×. The details per sample
of the sequenced and mapped fragments are reported in Table 3.
The variant calling procedure produced a list of 1,529 variant
sites that was reduced to 246 by filtering for SNVs. The set of
246 variant sites was then used to infer phylogeny. Phylogenetic
analysis using SNPrelate (Figure 6) shows that of the 10 samples
recorded during the investigation period, those from Milan
MI409 MI691 and MI031 belonged to one clade while the samples
from Verona (RS235, TP525, AA102, CG108, TN293, RO402,
ZY075) accounted for another cluster, with a node supported
by a z-score of 4.1 (p-value = 0.000041), with a final difference
of 61 mutations between the two clusters. In particular, inside
the second cluster, we observed a split between RS235 and the
rest of the samples with a node supported by a z-score of 2.3
(p-value = 0.021) and 16 mutations unique to each branch. The
phylogenetic analysis using Ape/Phangorn (Figure 7) shows the
same tree topology as in Figure 6.
Such analysis provides a bootstrap value as a measure of
statistical confidence: the higher the value, the larger the number
of mutations supporting the branch. In this analysis, the same
nodes in Figure 7 are supported with a bootstrap value of 100
indicating full separation between the groups identified in the
first analysis. The results for the first two principal components
of the data set that explain together ∼80% of variation are shown
in Figure 8.
The first component clearly divides the three samples MI409,
MI691, and MI031 from the others. The sample RS235 is partially
separated from the two main groups, consistent with results of
our phylogenetic trees. Four contigs out of the 339 present in the
genome assembly were identified as hypervariable; however, after
alignment with blastn, none of them had significant similarities
with sequences present in NCBI. Data set are available on request.
Environmental studies for possible sources of infection
included microbiology investigation of different dairy products,
and many medical devices and antibiotic formulations. In detail,
microbiological investigation was conducted on 10 different
yogurt products, 3 replicates of 3 different cheeses likely to
have been eaten by patients in hospital meals, as suspected
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FIGURE 5 | Correlation-based dendrograms obtained by (A) MALDI-TOF MS (Bruker Daltonics) and (B) MS-Vitek Saramis (bioMerieux, Marcy l’Etoile, France).
during the epidemiological investigation. Additionally, medical
devices, such as vascular catheters and platelet infusion kits,
were cultured. Also cultured were apheresis platelet concentrates
and plasma derivatives. Two different batches of amikacin,
gentamicin, and meropenem were cultured after enrichment in
BHI. The results of investigations of fungal contamination of
food, medical devices, blood derivatives, and antibiotics were
always negative.
Clinical Cases
Of the seven cases which occurred in Verona, clinical information
are available for only four.
The first case was a 20-year-old Italian girl with a T-ALL
diagnosis, admitted to our hematology ward for follow-
up chemotherapy. A few days after the first infusion she
became febrile with chills and broad spectrum antibiotics were
given. Blood cultures turned positive for yeast-like fungi, so
Caspofungin was added to therapy (Arendrup et al., 2014).
The patient developed progressive arterial hypotension and was
admitted to the ICU ward where she died of septic shock.
The fungus, which was first isolated from blood cultures, was
then identified as G. clavatum by means of Vitek-2. Drug
susceptibility test showed a high-level resistance to fluconazole
and all echinocandins.
TABLE 3 | Details of sequenced fragments for each strain of Saprochaete isolated
from Verona and Milan.
Sequenced Mapped Average
Sample fragments fragments coverage
RS235 16,282,394 14,335,384 216.59
RP402 24,467,857 22,739,883 331.26
AA102 16,692,742 14,796,911 218.73
CG108 13,899,852 12,314,272 187.31
TP525 14,058,887 12,582,330 186.30
TN293 24,179,648 18,491,452 278.89
ZY075 22,790,265 21,525,722 330.71
MI409 19,684,314 18,707,031 287.14
MI691 19,061,001 18,077,681 280.81
MI031 21,889,597 20,360,099 311.55
The second case was a 65–70-year-old Italian patient with
a cytotoxic NHL who was hospitalized in October 2016 in
the hematology ward for follow-up chemotherapy. Before
completing the cycle, he presented a high-grade fever, nausea
with vomiting, and diarrhea. As well as antibiotics for CVC
bacteremia due to Pseudomonas aeruginosa, he was given
liposomal amphotericin-B for G. clavatum fungemia for a total of
7 days, then switched to voriconazole for a further 10 days on the
basis of a drug susceptibility test. On CT scan, no disseminated
disease was reported and the patient was finally discharged home.
The third case was a 4-year-old Italian child with AML,
which was diagnosed when he was 1 year old. He started
chemotherapy soon after diagnosis with good initial response. In
October 2016 he was hospitalized because of a high-grade fever,
anemia, low platelets, and leukocytosis. On blood examination, a
recrudescence of his disease was evident, so new chemotherapy
FIGURE 6 | Phylogenetic tree produced by SNprelate, z-score at supported
nodes.
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FIGURE 7 | Phylogenetic tree produced by Ape/Phangorn, bootstrap value at
nodes.
was infused. After a few doses, he presented with a high-
grade fever, cough, and diarrhea. Broad spectrum antibiotics
and antifungals were given, after collection of blood cultures
(Camus et al., 2014). G. clavatum and St. epidermidis were
isolated, so targeted therapy with vancomycin and desoxycholate
amphotericin B was used for up to 15 days. He was then
discharged home and is still under hematology follow-up.
The fourth case was a 50–60-year-old Italian patient, admitted
in November 2016 to the hematology ward for relapsing
AML. During hospitalization, thanks to a good HLA match,
he underwent hematopoietic stem cell transplant (HSCT) after
induction chemotherapy. Five days after HSCT, he began to
complain of fever with chills, vomiting, and diarrhea. Despite
being on antifungal prophylaxis with Posaconazole, he developed
S. clavata fungemia. On PET-CT scan no disseminated disease
was reported. He received liposomal amphotericin B for 21 days
with no relapse and was discharged home 1 month later.
The three cases in Milan were comparable for age and clinical
history. They were Caucasian adult patients, admitted to the
hematology ward to start chemotherapy for AML. Because of
fever, blood was drawn for cultures. After being misidentified as
S. clavata, the strains were then recognized as S. capitata. AMB-L
and 5-FC therapy was started with resolution of symptoms.
DISCUSSION
While the general population is aging and experiencing multiple
chronic comorbidities, together with new and increasingly
complex therapies which strongly impact immune status, clinical
suspicion of infectious diseases caused by rare pathogens must
arise. Among these, fungi are playing an important role because
they are difficult-to-treat, slow progressing infections with high
morbidity and mortality. Unlike Aspergillus and Candida, little is
known about Saprochaete spp., formerly known as Geotrichum,
in immunosuppressed patients in terms of epidemiology, source
of outbreaks, risk factors, treatment, and outcomes.
The taxonomic classification of Geotrichum is currently
changing. It was originally known as Trichosporon spp. and
classified among the basidiomycetes (Gurgui et al., 2011).
Subsequently, due to its cell wall structure, septal pores, and
its tendency to produce numerous arthroconidia and few
blastoconidia, from a microbiological point of view it was
considered to be an ascomycete (Kurtzman and Robnett,
1997). Further reclassification has been made recently, thanks
to novel and finer microbiological techniques which rely on
proteome and genome sequencing. Geotrichum species is now
defined as Saprochaete even though some experts name it
Magnusiomyces (Desnos-Ollivier et al., 2014; Vaux et al., 2014).
Misidentification is frequent due to their similar phenotypes
and limited information collected in the databases. As a
consequence, differentiation may be very difficult when based on
macroscopic and microscopic analysis. Colonies present white,
farinose, dry with frosted glass appearance, and microscopic
features consist of true hyphae organized in acute branches often
disarticulated into arthroconidia with rectangular or rounded
ends (Desnos-Ollivier et al., 2014).
The first case of Geotrichum infection was reported in
1965, and to date other cases or small outbreaks have been
described, predominantly in Italy and France (Gadea et al., 2004;
Girmenia et al., 2005; Del Principe et al., 2016; Esposto et al.,
2018; Stanzani et al., 2019). Clinical presentations were sepsis,
pulmonary hepatic and splenic lesions, brain abscesses, and were
characterized by a high mortality rate, due to peculiar antifungal
resistance patterns, difficult identification and, consequently,
delay in diagnosis and correct treatment (Gadea et al., 2004;
Cuenca-Estrella et al., 2011; Esposto et al., 2018). A 20-year
observational multicenter Italian study reported 35 cases of
G. capitatum infection, with a mortality rate of 57.1% (Girmenia
et al., 2005; Esposto et al., 2018). Most of those cases occurred
in patients with hematology malignancies, especially during
profound neutropenia due to chemotherapy.
The optimal therapy has yet to be established and remains
a challenge (White et al., 1990; Kurtzman and Robnett,
1997; Arendrup et al., 2014), because they are rare, subtle,
and difficult-to-diagnose infections, with no current available
breakpoints from EUCAST nor CLSI and intrinsic resistance to
echinocandins and fluconazole.
Here we report a small cluster of seven S. clavata infections
occurring between September 2016 and July 2017 in the
Azienda Ospedaliera Universitaria Integrata di Verona, Italy.
All infections developed in adult and pediatric hematology
patients. Each case was matched with five controls on the basis
of the ward of hospitalization during fungal sepsis. Of note,
all clinical cases had experienced severe neutropenia following
chemotherapy; had a CVC or other central vascular device;
were given broad-spectrum antibiotics and transfusions; and had
high-grade fever with chills, diarrhea, and vomiting. Significant
associations with transfusions and antibiotics may be explained
by the fact that almost all cases were septic and needed stronger
supportive therapies than the controls. As seen in other reports,
all of our patients who had experienced S. clavata fungemia
were severely immunocompromised, underscoring that the most
important epidemiological risk factor for this kind of infection
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FIGURE 8 | Principal component analysis of 199 informative SNPs.
is immunosuppression and in particular neutropenia. It is
noteworthy that, among patients of our hospital whose blood
cultures turned positive for S. clavata, one tested positive also for
stool, strengthening the hypothesis that this fungus can colonize
the gut mucosa and migrate into the circulation or vice versa, as
Candida spp. does. Probably, gut colonization and translocation,
caused by chemotherapy-induced intestinal tract damage or
mucositis, may have played an important role (Camera et al.,
2003; Lee et al., 2014). In addition, we cannot exclude that
Saprochaete could colonize the skin from the environment and
invade the blood system through portals of entry such as catheters
or wounds. As a retrospective study, the gut colonization of all the
patients was not investigated, except for the last one.
Unlike previous historical outbreaks, mortality was not
very high, thanks to rapid molecular identification and start
of amphotericin B formulations, which is the recommended
therapy for now, given intrinsic resistance to echinocandins
and fluconazole.
Saprochaete clavata grew from all blood cultures and
identification was made with SARAMIS-MS Vitek (bioMerieux,
Marcy l’Etoile, France) and nucleotide sequencing. Actually,
whole-genome sequence (WGS) typing is the best available
molecular method to evaluate the clonality of a suspected
outbreak caused by uncommon fungal species (Alanio et al., 2017;
Bougnoux et al., 2018). It is based on the analysis of whole single-
nucleotide polymorphisms (SNPs) within each genome, which
enables comparison between strains. The number of different
SNPs and their distances allow for inference of strains relatedness.
Phylogenetic analysis using SNPrelate (Figure 6) showed that the
seven samples from the Verona outbreak belonged to one clade.
We observed a split between RS235 and the rest of the samples
caused by 16 mutations, but further and more robust studies are
needed to explain their significance. Vaux et al. (2014) described
a nationwide outbreak which occurred in the spring of 2012
involving 10 health-care facilities in France, due to one clade of
S. clavata. Even though they made a nationwide microbiological
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and epidemiological investigation, they did not find the source of
infection; however, food, especially dairy products, or apheresis
platelet concentrates were strongly suspected. In our outbreak
we observed seven cases in a very short period of time and
we deemed that a common, easily diffusible source of infection
could have been present in our hospital. We checked for
diverse potential vehicles of infection although microbiology
results were always negative. Because, during neutropenia and
chemotherapy-induced mucositis the risk of gut translocation
is high, we thought that food could have been one of the
most likely sources. We then tested and cultured some dairy
products (yogurt, creamy cheese), as our French colleagues had
done before. Unfortunately, the retrospective nature of food
investigation precluded collection of all potential sources of
contamination, and microbiology gave negative results. Aside
from foods, medical devices, and drugs, we did not perform
culture investigation on healthcare providers as potential vectors
of infection. As such, we cannot make conclusions on how
the epidemic began; microbiology was always negative, so we
could neither find a source of infection nor implement a plan to
control or avoid it.
This is the largest outbreak by a rare fungus ever observed
in our hospital, worthy to be described, and evaluated
from a microbiological point of view. One strength of our
work is that the clonal relatedness of our isolates relied
on a proteomic approach, using two of the most diffuse
mass spectrometry machines available in microbiology clinical
laboratories, the Bruker and the Biomerieux MS Vitek. The
clonality of the strains was evidenced by the clustering during
proteomic evaluation. Both Bruker MALDI Biotyper system
and bioMerieux MS-VITEK showed high similarity of the
isolates. Interestingly, both systems highlighted that one different
isolate did not strictly correlate with the other six. Few other
reports have tried to discuss the usefulness of proteomic
fungal typing by means of MALDI-TOF, which was able
to describe and confirm strains’ relatedness in an outbreak
(Stanzani et al., 2019).
To date many papers have shown the ability of MALDI-TOF
in accurately distinguishing different clusters of Candida strains,
geographically grouped as in the case of Candida auris (Pracash
et al., 2016) or in the case of multidrug resistant Candida glabrata
(Dhieb et al., 2015) and Candida parapsilosis complex (De
Carolis et al., 2014). MALDI-TOF mass spectra for genotyping
would represent a rapid, first-level, easy, and cost-effective way
to support clinicians, during uncommon fungal outbreaks, in
treatment decision-making and in a clinical microbiology lab,
although only WGS can confirm it. Of course, further studies
are needed to strengthen the accuracy and efficacy of MALDI-
TOF as a fungal typing tool even in rare infections. Although
rare, S. clavata should be considered as a potential cause of IFI,
particularly in cases of severe neutropenia. Last, but not least,
its intrinsic resistance to echinocandins and fluconazole must be
considered when selecting an empirical antifungal therapy as this
infection may be rapidly lethal. National surveillance is desirable
to successfully investigate multicenter outbreaks of infection due
to rare pathogens.
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